Joel Greenblatt’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Joel Greenblatt's DFTX Position: Q3 2026 in Review
Joel Greenblatt sold out of Definium Therapeutics (DFTX) in Q3 2026, closing a stake of 4,412 shares — an estimated $208K sold.
Joel Greenblatt first reported a position in DFTX in Q2 2025 and held it in 4 quarters. The position peaked at $239K in Q4 2025. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Joel Greenblatt reported no remaining Definium Therapeutics position as of Q3 2026 after selling out during the quarter.
- Joel Greenblatt sold 4,412 Definium Therapeutics shares in Q3 2026, an estimated $208K.
- Joel Greenblatt first reported a position in Definium Therapeutics in Q2 2025 and held it in 4 quarters.
- Joel Greenblatt's Definium Therapeutics position peaked at $239K in Q4 2025.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.